Mandatum Life Insurance CO LTD Bristol Myers Squibb CO Transaction History

Mandatum Life Insurance CO LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$53.63 - $62.52 $2.03 Million - $2.37 Million	-37,939 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$57.43 - $63.64 $28,198 - $31,247	-491 Reduced 1.28%	37,939 $2.29 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $26,916 - $31,468	491 Added 1.29%	38,430 $2.26 Million
Q4 2019 Feb 11, 2020	BUY	$49.21 - $64.19 $1.87 Million - $2.44 Million	37,939 New	37,939 $2.44 Million
Q3 2019 Nov 08, 2019	SELL	$42.77 - $50.71 $916,347 - $1.09 Million	-21,425 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$44.62 - $49.34 $164,067 - $181,423	3,677 Added 20.72%	21,425 $972,000
Q1 2019 May 13, 2019	BUY	$45.12 - $53.8 $800,789 - $954,842	17,748 New	17,748 $847,000

2,536

1.46B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Mandatum Life Insurance CO LTD, based on Form 13F filings with the SEC.

Stay updated on Mandatum Life Insurance CO LTD with notifications on news.